APIOC for Presbyopia and APIOC for Presbyopia for Astigmatism
DeviceContact Lenses for Presbyopia
NCT Number: NCT04883099
Vision and comfort, both objective and subjective, will be assessed for single vision contact lens wearers for either the APIOC™ for Presbyopia or the APIOC™ for Presbyopia Astigmatism contact lenses.
Looking for future studies?
Notify Me40 year–70 year
All sexes
Interventional
Not applicable
Complete Family Vision Care, San Diego, California, United States
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Contact Lenses for Presbyopia
Time frame: Day 7
High and Low Contrast LogMAR
Time frame: Day 7
Visual analogue scale (0-100 points) 100 is best possible quality of vision
Time frame: Day 7
Visual analogue scale(0-100 points) 100 is best possible comfort
Time frame: Day 7
High and Low Contrast
Time frame: Day 7
High and Low Contrast
Time frame: Day 7
Compared to habitual lenses, rated as better/same/worse
Time frame: Day 7
Compared to habitual lenses, rated as better/same/worse
Lentechs, LLC
Industry
7 Day Trial of APIOC for Presbyopia and APIOC for Presbyopia With Astigmatism
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07291739
Astigmatism, Eye Diseases
Makati City, Philippines
View Trial DetailsNCT04208750
Astigmatism, Eye Diseases
Bloomington, Indiana, United States
View Trial DetailsNCT03688672
Ametropia, Astigmatism
Columbus, Ohio, United States
View Trial DetailsNCT01809197
Astigmatism, Eye Diseases
View Trial Details